Estimated 2-year PFS2 with 2L BTKi in relapsed/refractory mantle cell lymphoma

Estimate 2-year Mantle Cell Lymphoma PFS2

About

Estimated 2-year PFS2 with 2L BTKi in relapsed/refractory mantle cell lymphoma

References

D. Villa, A. Jiang, N. Crosbie, S. Rule, R. McCulloch et al,

Hematological Oncology: 17 June 2021
Default Units

1. MIPI risk category at diagnosis?

0/4 completed

About

Estimated 2-year PFS2 with 2L BTKi in relapsed/refractory mantle cell lymphoma

References

D. Villa, A. Jiang, N. Crosbie, S. Rule, R. McCulloch et al,

Hematological Oncology: 17 June 2021
Contributed By:
  • Aixiang Jiang
Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.